Mou S - Search Results

1

Feasibility of Urgent-Start Peritoneal Dialysis in Older Patients with End-Stage Renal Disease: A Single-Center Experience.

Jin H, Ni Z, Mou S, Lu R, Fang W, Huang J, Hu C, Zhang H, Yan H, Li Z, Yu Z. Jin H, et al. Among authors: mou s. Perit Dial Int. 2018 Mar-Apr;38(2):125-130. doi: 10.3747/pdi.2017.00002. Epub 2017 Nov 21. Perit Dial Int. 2018. PMID: 29162677

2

[Relationship of brain natriuretic peptide to renal function and left ventricular hypertrophy in patients with chronic kidney disease].

Zhou WY, Ni ZH, Gu LY, Fang W, Wang Q, Mou S, Cao LO, Yu ZZ, Qian JQ. Zhou WY, et al. Among authors: mou s. Zhonghua Yi Xue Za Zhi. 2007 Dec 11;87(46):3284-7. Zhonghua Yi Xue Za Zhi. 2007. PMID: 18396626 Chinese.

3

[Diagnostic value of CT peritoneography for non-infectious complications of peritoneal dialysis].

Wang Q, Ni ZH, Zhu ML, Mou S, Cao LO, Fang W. Wang Q, et al. Among authors: mou s. Zhong Xi Yi Jie He Xue Bao. 2008 May;6(5):478-81. doi: 10.3736/jcim20080509. Zhong Xi Yi Jie He Xue Bao. 2008. PMID: 18471411 Chinese.

4

[Expression of c-met in human kidney fibroblasts induced by high glucose in vitro and the regulation of Radix Astragali].

Mou S, Ni ZH, Zhang QY. Mou S, et al. Zhong Xi Yi Jie He Xue Bao. 2008 May;6(5):482-7. doi: 10.3736/jcim20080510. Zhong Xi Yi Jie He Xue Bao. 2008. PMID: 18471412 Chinese.

5

Hepatocyte growth factor suppresses transforming growth factor-beta-1 and type III collagen in human primary renal fibroblasts.

Mou S, Wang Q, Shi B, Gu L, Ni Z. Mou S, et al. Kaohsiung J Med Sci. 2009 Nov;25(11):577-87. doi: 10.1016/S1607-551X(09)70560-1. Kaohsiung J Med Sci. 2009. PMID: 19858036 Free article.

6

Hepatocyte growth factor ameliorates progression of interstitial injuries in tubular epithelial cells.

Mou S, Wang Q, Shi B, Gu L, Ni Z. Mou S, et al. Scand J Urol Nephrol. 2010 Mar;44(2):121-8. doi: 10.3109/00365590903449340. Scand J Urol Nephrol. 2010. PMID: 20001204

7

Prevalence of non-diabetic renal disease in patients with type 2 diabetes.

Mou S, Wang Q, Liu J, Che X, Zhang M, Cao L, Zhou W, Ni Z. Mou S, et al. Diabetes Res Clin Pract. 2010 Mar;87(3):354-9. doi: 10.1016/j.diabres.2009.11.012. Epub 2009 Dec 14. Diabetes Res Clin Pract. 2010. PMID: 20005594

8

Circulating levels of asymmetric dimethylarginine are an independent risk factor for left ventricular hypertrophy and predict cardiovascular events in pre-dialysis patients with chronic kidney disease.

Shi B, Ni Z, Zhou W, Yu Z, Gu L, Mou S, Fang W, Wang Q, Cao L, Yan Y, Qian J. Shi B, et al. Among authors: mou s. Eur J Intern Med. 2010 Oct;21(5):444-8. doi: 10.1016/j.ejim.2010.07.001. Epub 2010 Jul 24. Eur J Intern Med. 2010. PMID: 20816602

9

High-sensitivity C-reactive protein: an independent risk factor for left ventricular hypertrophy in patients with lupus nephritis.

Shi B, Ni Z, Cai H, Zhang M, Mou S, Wang Q, Cao L, Yu Z, Yan Y, Qian J. Shi B, et al. Among authors: mou s. J Biomed Biotechnol. 2010;2010:373426. doi: 10.1155/2010/373426. Epub 2010 Nov 7. J Biomed Biotechnol. 2010. PMID: 21076530 Free PMC article.

10

Urinary excretion of liver-type fatty acid-binding protein as a marker of progressive kidney function deterioration in patients with chronic glomerulonephritis.

Mou S, Wang Q, Li J, Shi B, Ni Z. Mou S, et al. Clin Chim Acta. 2012 Jan 18;413(1-2):187-91. doi: 10.1016/j.cca.2011.09.018. Epub 2011 Sep 17. Clin Chim Acta. 2012. PMID: 21958699

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

521 results

Search Page

Filters